 | ||
   | ||
Email
Glossary |
|
Volunteering for phase 3 Gilead GS-9350 study Sep 29, 2010 What are the pros and cons of taking part in this study: Gilead Sciences phase 3 randomized double blind Elvitegravir emtricitabine tenofovir disoproxil fumarate gs-9350 versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate? What questions should I ask and where can I go for objective information? |
||||||||
 |
||||||||||
|
||||||||||
 |
| Response from Dr. McGowan
 Thanks for your question. For full disclosure, I should tell you that I am an investigator on this study. One thing that is important in a study is that the arms are balanced. Especially in a phase 3 study, whichever arm you get assigned there should be a reasonable chance that you are getting a treatment that has a potential benefit. This study does meet this basic criteria. Data can be found at "HIV and Hepatitis" (http://www.hivandhepatitis.com/2010_conference/icaac/docs/0914_a.html), or POZ (http://www.poz.com/articles/hiv_quad_cobicistat_761_19095.shtml) Best, Joe | ||||||||
 Get Email Notifications When This Forum Updates or Subscribe With RSS
|
||||||||||
|
||||||||||
Q&A TERMS OF USE
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.
Review our complete terms of use and copyright notice.
